Steven Gitelis to Cyclin-Dependent Kinase Inhibitor p27
This is a "connection" page, showing publications Steven Gitelis has written about Cyclin-Dependent Kinase Inhibitor p27.
Connection Strength
0.166
-
Crosstalk between the IGF-1R/AKT/mTORC1 pathway and the tumor suppressors p53 and p27 determines cisplatin sensitivity and limits the effectiveness of an IGF-1R pathway inhibitor. Oncotarget. 2016 May 10; 7(19):27511-26.
Score: 0.137
-
Increasing cisplatin sensitivity by schedule-dependent inhibition of AKT and Chk1. Cancer Biol Ther. 2014; 15(12):1600-12.
Score: 0.029